ArticleDiabetes, obesity & metabolism2023

Once-weekly semaglutide versus insulin aspart for the treatment of type 2 diabetes in the UK: A long-term cost-effectiveness analysis based on SUSTAIN 11.

Marc Evans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.